Low-Molecular-Weight Heparin in the Treatment of Patients With Venous Thromboembolism (original) (raw)
Low molecular weight heparin versus unfractionated heparin in the initial treatment of venous thromboembolism
Martin Prins
Current Opinion in Pulmonary Medicine, 1998
View PDFchevron_right
Comparison of Fixed-Dose Weight-Adjusted Unfractionated Heparin and Low-Molecular-Weight Heparin for Acute Treatment of Venous Thromboembolism
Susan Solymoss, Jeffrey Ginsberg
JAMA, 2006
View PDFchevron_right
Unfractionated versus low-molecular-weight heparin in the treatment of venous thromboembolism
menab men
View PDFchevron_right
Suboptimal doses of low molecular weight heparin and acute venous thromboembolism. Data from the RIETE registry
Monserrat Jimenez
Annals of Hematology, 2007
View PDFchevron_right
Treatment of acute venous thromboembolism with low molecular weight heparin (Fragmin). Results of a double-blind randomized study
Henry Eriksson
Circulation, 1989
View PDFchevron_right
Secondary Prevention of Venous Thromboembolism: A Role for Low-Molecular-Weight Heparin
Manuel Monreal
Pathophysiology of Haemostasis and Thrombosis, 1998
View PDFchevron_right
Therapeutic Application of Subcutaneous Low-Molecular-Weight Heparin in Acute Venous Thrombosis
Hermann Bratsch
Pathophysiology of Haemostasis and Thrombosis, 1990
View PDFchevron_right
Low-Molecular-Weight Heparin Use with Thrombolysis: Is it Effective and Safe? Ten Years' Clinical Experience
Leyla Saglam
Respiration, 2013
View PDFchevron_right
A Randomized Trial Comparing 2 Low-Molecular-Weight Heparins for the Outpatient Treatment of Deep Vein Thrombosis and Pulmonary Embolism
Melissa Forgie
Archives of Internal Medicine, 2005
View PDFchevron_right
Comparative effectiveness of low-molecular-weight heparin versus unfractionated heparin for thromboembolism prophylaxis for medical patients
Soyon Lee
Journal of Hospital Medicine, 2012
View PDFchevron_right
Outpatient therapy with low molecular weight heparin for the treatment of venous thromboembolism: a review of efficacy, safety, and costs
Jodi Segal, Jerry Krishnan, Michael Streiff
The American Journal of Medicine, 2003
View PDFchevron_right
Low-molecular-weight heparin (LMWH) in the treatment of thrombosis
René G Holzheimer
European journal of medical research, 2004
View PDFchevron_right
Low-Molecular-Weight Heparins for the Prevention and Treatment of Venous Thromboembolism
Gia Dice
Military Medicine, 2001
View PDFchevron_right
Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: Results of a meta-analysis
Sergio Siragusa
The American Journal of Medicine, 1996
View PDFchevron_right
Major bleedings in the comparisons between low-molecular weight heparin versus oral anticoagulant therapy for venous thromboembolism
Diana Giannarelli
Thrombosis Research, 2007
View PDFchevron_right
Low molecular weight heparin (dalteparin) is equally effective as unfractionated heparin in reducing coagulation activity and perfusion abnormalities during the early treatment of pulmonary embolism
Fred Verzijlbergen
2004
View PDFchevron_right
Low-molecular-weight or Unfractionated Heparin in Venous Thromboembolism: The Influence of Renal Function
Pedro Gallego
The American Journal of Medicine, 2013
View PDFchevron_right
Low molecular weight heparin in prevention of perioperative thrombosis
Francois Chapuis
BMJ, 1992
View PDFchevron_right
Outpatient treatment of venous thromboembolism using low molecular weight heparins. An overview
Miltiadis Matsagkas
2004
View PDFchevron_right
Low-molecular-weight heparin for thromboprophylaxis
Giuseppe Camporese
Current opinion in pulmonary medicine, 2009
View PDFchevron_right
Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis
Anthonie Lensing
Archives of Internal Medicine, 1995
View PDFchevron_right
A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis
Susan Haley, Jean Cusson, Jack Hirsh, Jeffrey Ginsberg
New England Journal of Medicine, 1996
View PDFchevron_right
Assessment of Outpatient Treatment of Deep-Vein Thrombosis With Low-Molecular-Weight Heparin
Jeffrey Ginsberg
Archives of Internal Medicine, 1998
View PDFchevron_right
Randomised controlled trial for efficacy of unfractionated heparin (UFH) versus low molecular weight heparin (LMWH) in thrombo-prophylaxis
shailesh kakde
PubMed, 2013
View PDFchevron_right
The Use of Low Molecular Weight Heparin for Venous Thromboembolism Prophylaxis in Medical Patients: How Much Are We Adherent to the Guidelines?
Lamia alhajri
Open Journal of Internal Medicine, 2015
View PDFchevron_right
Bleeding and Thrombotic Risk in Low Dose Heparin Infusion as Compared to Standard Dose Heparin Infusion
Rohit Bishnoi
Cureus, 2020
View PDFchevron_right
Low molecular weight heparin once daily compared with conventional low-dose heparin twice daily. A prospective double-blind multicentre trial on prevention of postoperative thrombosis
Bo Risberg, Jan Frisell
British Journal of Surgery, 1986
View PDFchevron_right
A Randomized Trial Comparing Activated Thromboplastin Time With Heparin Assay in Patients With Acute Venous Thromboembolism Requiring Large Daily Doses of Heparin
Jeffrey Weitz
Archives of Internal Medicine, 1994
View PDFchevron_right